著者
Shingo Fukuma Tatsuyoshi Ikenoue Yukari Yamada Yoshiyuki Saito Joseph Green Takeo Nakayama Shunichi Fukuhara
出版者
Japan Epidemiological Association
雑誌
Journal of Epidemiology (ISSN:09175040)
巻号頁・発行日
vol.31, no.7, pp.410-416, 2021-07-05 (Released:2021-07-05)
参考文献数
39
被引用文献数
3

Background: Breaches of ethics undermine the practice of medicine. In Japan, two major scandals involving clinical research and drug marketing occurred after the publication of clinical trials. To study the effects of those scandals, we evaluated changes in the use of first-generation angiotensin II receptor blockers (ARBs) after publication of relevant clinical trials and also after the subsequent scandals.Methods: We conducted a quasi-experimental design of an interrupted time series analysis (ITSA) on nationwide monthly drug-market data covering 12 years (2005 to 2017) in Japan. The main outcome was the use of first-generation ARBs (valsartan, candesartan, and losartan). The two exposures were the publication of ARB-related clinical-trial results (October 2006) and subsequent ARB-related scandals involving research and marketing (February 2013). A generalized estimating equation model was fitted for ITSA with a log link, Poisson distribution, robust variance estimators, and seasonality adjustment.Results: The publication of clinical trials was associated with 12% increase in the use of first-generation ARBs in Japan, and the subsequent ARB-related scandals was associated with 19% decrease. The decrease in the use of first-generation ARBs after the scandals was greater than the increase in their use after the publication of clinical-trial results. The net effect of the two exposures was a 9% decrease in the use of first-generation ARBs.Conclusions: The scandals were associated with decrease in the use of first-generation ARBs, and that decrease was greater than the increase associated with the publication of “successful” clinical trials, making the net effect not zero but negative.
著者
Shingo Fukuma Tatsuyoshi Ikenoue Yukari Yamada Yoshiyuki Saito Joseph Green Takeo Nakayama Shunichi Fukuhara
出版者
Japan Epidemiological Association
雑誌
Journal of Epidemiology (ISSN:09175040)
巻号頁・発行日
pp.JE20200181, (Released:2020-07-04)
参考文献数
39
被引用文献数
3

BackgroundBreaches of ethics undermine the practice of medicine. In Japan, two major scandals involving clinical research and drug marketing occurred after the publication of clinical trials. To study the effects of those scandals, we evaluated changes in the use of first-generation angiotensin II receptor blockers (ARBs) after publication of relevant clinical trials and also after the subsequent scandals.MethodsWe conducted a quasi-experimental design of an interrupted time series analysis (ITSA) on nationwide monthly drug-market data covering 12 years (2005 to 2017) in Japan. The main outcome was the use of first-generation ARBs (valsartan, candesartan, and losartan). The two exposures were the publication of ARB-related clinical-trial results (October 2006) and subsequent ARB-related scandals involving research and marketing (February 2013). A generalized estimating equation model was fitted for ITSA with a log link, Poisson distribution, robust variance estimators, and seasonality adjustment.ResultsThe publication of clinical trials was associated with 12% increase in the use of first-generation ARBs in Japan, and the subsequent ARB-related scandals was associated with 19% decrease. The decrease in the use of first-generation ARBs after the scandals was greater than the increase in their use after the publication of clinical-trial results. The net effect of the two exposures was a 9% decrease in the use of first-generation ARBs.ConclusionsThe scandals were associated with decrease in the use of first-generation ARBs, and that decrease was greater than the increase associated with the publication of “successful” clinical trials, making the net effect not zero but negative.
著者
Yoshiyuki Saito Sunao Uchida Yoshiko Yabe Makoto Miyazaki
出版者
Japan Society of Physical Education, Health and Sport Sciences
雑誌
International Journal of Sport and Health Science (ISSN:13481509)
巻号頁・発行日
vol.15, pp.1-5, 2017 (Released:2017-04-18)
参考文献数
5

Psychological studies have shown that when individuals move their gaze between two alternative objects, they tend to choose the object that holds their gaze for longer (the gaze-manipulation effect). This effect is especially evident when both alternatives appeal to the viewer. We hypothesized that if individuals have an interest in sports and/or fashion, and thus view varieties of sportswear favorably, then gaze manipulation would influence their choice. Japanese university students participated in our experiments. The participants made preference choices between two uniforms of European football teams, which were presented alternately across the left and right sides of a computer screen six times for different durations (900 ms vs. 300 ms). They were required to compare the uniforms with or without fixing their gaze directly on them. They also completed questionnaires designed to assess their interest in football and fashion. The results showed that the gaze-manipulation effect was not significant across all participants or across those participants who merely liked fashion, or who merely watched football or casually played it. However, the effect was significant in participants who had been members of football teams. Our results suggest that application of the gaze-manipulation technique would be more effective for visual advertisement of sports items if it was focused on sports players.